This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The bipartisan bill would amend title XVIII of the Social Security Act to set up appropriate payment of certain algorithm-based healthcare services under the Medicare program. Medicare patients deserve access to the life-changing care that artificial intelligence-enabled devices can offer,said Rounds in a prepared statement.
The new MRI Safety procedures are as follows: CPT Code Description RVU Value Medicare Fee 76014 MR safety implant and/or foreign body assessment, initial 15 minutes G - 0.33 $10.67 Medicare Fee represents the national level using the CF of $32.3465 in effect as of this writing. 76015 Add-on Each additional 30 minutes G - 1.59 $51.43
PET, CT, and MRI use for assessing coronary artery disease increased in Medicare patients from 2018 to 2022, while SPECT and stress echocardiography declined over the same period, researchers have reported. Taken together, these findings call for efforts to address barriers impeding wider uptake of PET,” the group wrote.
Higher Medicaid-to-Medicare reimbursement ratios (MMRR) are linked to increased likelihood of Medicaid patients receiving CT, MR, ultrasound, and x-ray imaging, researchers have reported. Medicare reimbursement levels are set by individual states, and they vary across the U.S., The research included data from 4.9 Nuclear medicine 0.76
Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease. GE HealthCare's launch coincides with the receipt of pass-through status by the Centers for Medicare & Medicaid Services (CMS), effectiveApril 1st.
Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PET scan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PET scans will now be made by local Medicare Administrative Contractors (MACs).
A group of Medicare Administrative Contractors (MACs) have approved coverage of Cleerly's AI-enabled quantitative coronary topography scans for Medicare recipients with symptoms of coronary artery disease (CAD). MACs provide coverage for 34 million Medicare beneficiaries, Cleerly said.
The 2025 Medicare reimbursement updates bring significant changes for healthcare providers, particularly in coronary computed tomography angiography (CCTA) and other imaging services. tctmd.com ) Key Impacts on Imaging Facilities Many high-volume imaging procedures will see reduced Medicare payments, including mammography and ultrasound.
Cardiac PET MPI has emerged as a key tool for diagnosing and managing patients with cardiovascular diseases, especially coronary artery disease, yet overall it remains underutilized in the U.S., Strategies to increase the use of cardiac PET myocardial perfusion imaging (MPI) in the U.S. the authors noted.
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).
Alzheimer’s disease patients with cognitive impairment or dementia who were referred for amyloid PET scans had fewer hospitalizations compared with a matched control group, according to a study published October 9 in JAMA Neurology. Eligible participants were Medicare beneficiaries 65 years or older with a diagnosis of MCI or dementia.
Whether a woman is covered by Medicare or by commercial insurance appears to influence the type of treatment she will likely undergo for uterine fibroids, researchers have reported. The complete study can be found here.
milla1cf Wed, 10/18/2023 - 13:29 October 18, 2023 — The Centers for Medicare and Medicaid Services (CMS) announced it will no longer require coverage with evidence development (CED) for beta-amyloid positron emission tomography (PET) dementia care use. ACR staff will continue to update members as further information is released.
Medicare payer's perspective over four years, noted lead author Daniel Kwak, MD, PhD, of the University of Chicago, and colleagues. “In Osteoarthritis is a leading cause of chronic pain and long-term disability in adults, with more than 80% of cases involving the knee, and the estimated healthcare costs associated with the disease in the U.S.
Flyrcadois a unit-dose PET myocardial perfusion imaging (MPI) agent intended for patients with known or suspected coronary artery disease. GE HealthCare's launch coincides with the receipt of pass-through status by the Centers for Medicare & Medicaid Services (CMS), effectiveApril 1st.
1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the Hospital Outpatient Prospective Payment System (HOPPS). tim.hodson Thu, 11/07/2024 - 11:25 Nov.
Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert. million coronary artery disease procedures per year. Despite a proposal by the U.S. We would see a drop of approximately 3% in the reimbursement per SPECT study performed,” he said.
echocardiography) for congenital heart disease, diagnostic; 76987 including placement and manipulation of transducer, image acquisition, interpretation, and report 76988 placement, manipulation of transducer, and image acquisition only. for the professional component, using the national Medicare reimbursement rates.
The current guidelines recommend women with a personal history of the disease and who have dense breasts or cancer diagnosis before age 50 for supplemental breast MRI. Patients with commercial insurance had higher MRI uptake than those with Medicare/Managed Care (p = 0.0034).
Centers for Medicare and Medicaid Services (CMS) said it will cove. Brain PET patterns emerge in early Alzheimer's patients Brain PET imaging reveals role of serotonin in Alzheimer's disease FDA approves new drug for Alzheimer's disease CMS delays decision on amyloid PET coverage
The Society of Cardiovascular Computed Tomography (SCCT) applauded final local coverage determinations (LCDs) for AI-coronary plaque analysis (AI-CPA) released by four of the seven Medicare administrative contractors (MACs). The four contractors for the U.S. The LCDs have a future effective date of November 24, 2024.
The use of coronary artery calcium (CAC) scanning for heart disease diagnosis is influenced by regional and socioeconomic factors, according to research presented at the Society of Cardiovascular Computed Tomography (SCCT) meeting in Washington, DC. relative to [CAD] prevalence."
We're seeing now is that cardiac CT is a fantastic test to rule out the presence of flow-limiting coronary disease," Leiner said, adding that the future is not about single algorithms. The program addresses the heart and vasculature and complements Mayo Clinic's ongoing work in cardiac AI and AI coronary analysis.
Despite this focus, Menard was not a supporter of the Protecting Access to Medicare Act (PAMA) and appropriate use criteria (AUC) for medical imaging, which, he contended, were bad policies from the start. Medicare has announced that it plans to outsource 100% of fee for service or traditional Medicare to risk-sharing arrangements by 2030.
Cleerlys software is designed to identify heart disease by analyzing noninvasive images. In the announcement, James Min, MD, founder and CEO, noted recent achievements in attaining Medicare coverage and aCurrent Procedural Terminology (CPT) Category I code for coronary plaque analysis. Food and Drug Administration (FDA).
Because factors such as financial distress have been linked to higher mortality rates among patients with cancer -- in part because people may not get the screening exams they need and thus present with more advanced disease, wrote a team led by Samilia Obeng-Gyasi, MD, of the Ohio State University in Columbus.
Note that direct supervision is required for contrast administration if it is not performed by the physician, and the normal precautions for patients with renal disease or iodine allergies apply. At the federal level, the Find It Early Act (H.R. 3086) was introduced in May 2023 and currently has 73 co-sponsors.
But as in Q3, they're not optimistic that their departments will receive adequate Medicare reimbursement for exams. But the survey also reported that all regions except the South Atlantic had very low or low confidence in receiving adequate Medicare reimbursement. More chronic diseases will require more intensive care."
Referring physicians and other providers may consult the ACR AC to fulfill requirements mandated by the Protecting Access to Medicare Act, which requires that they consult appropriate use criteria prior to ordering advanced diagnostic imaging for Medicare patients. For more information: www.acr.org Tuesday, April 11, 2023 - 21:21
This study describes trends in surgical versus endovascular interventions for treatment of chronic superficial venous disease (SVD) in the Medicare population. Medicare Part B data from 2010-2018 was obtained. Claims for SVD treatment were identified using Healthcare Common Procedure Coding System (HCPCS) codes.
discussed the potential impact of the recent CMS proposal to rein in Medicare coverage restrictions on the use of amyloid positron emission tomography (PET) for patients with Alzheimer’s disease. In a video interview, Jacob Dubroff, M.D.,
Recognizing the advent of beta amyloid-targeted therapies for the treatment of Alzheimer’s disease, the Centers for Medicare and Medicaid (CMS) has proposed eliminating coverage restrictions that limit amyloid positron emission tomography (PET) scans to clinical trial participants and one amyloid PET scan per lifetime.
30, 2025 Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,
Centers for Disease Control and Prevention and consists of information from more than 400,000 interviews with adults each year. Centers for Medicare and Medicaid Services' (CMS) removal of the requirement for facilities to report lung cancer screening exams to a registry -- specifically the ACR's LCSR.
It was prompted by the fact that smokers have an increased risk of not just lung cancer but complex comorbidities—including cardiovascular or cerebrovascular disease and chronic obstructive pulmonary disease—from their tobacco exposure.
In 2003, CDL Nuclear was born, and we are making offering Cardiac PET easier than ever before; an expansion of our existing services now includes bringing cardiac PET to your doorstep and making it possible to offer patients this advanced, accurate and highly requested diagnostic modality.
The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor. The guideline is published in Practical Radiation Oncology.
NeuroShield takes 3D MR images as inputs and automatically calculates brain volumes that can assist physicians in devising treatment plans for patients with neurodegenerative diseases such as Dementia, Alzheimer's' Disease, Parkinson's, and Epilepsy. Globally, over a billion people suffer from neurodegenerative disorders.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content